RH · Rh
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $56.9M | Q1 FY2026 | — |
| Adjusted EBITDA Margin non-GAAP | 7.1% | Q1 FY2026 | — |
|
|
|||
| Free Cash Flow | $13.3M | Q1 FY2026 | — |
|
|
|||
| Adjusted Operating Margin non-GAAP | 11.4% | FY2025 | — |
| EBITDA Margin | 15.9% | FY2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Retail — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RH
this stock
Rh
|
$3.26B | -5.1% | +24.5% | 33.3 | 27.4% |
|
CASY
Caseys General Stores Inc
|
$31.64B | +51.3% | +10.2% | 44.6 | 4.6% |
|
WSM
Williams Sonoma Inc
|
$28.42B | +35.7% | +1.2% | 27.1 | 4.8% |
|
ULTA
Ulta Beauty, Inc.
|
$22.21B | -12.8% | +9.7% | 19.4 | 5.4% |
|
BBY
Best Buy Co Inc
|
$18.39B | +33.3% | +0.4% | 16.2 | 7.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RH | -5.7% | -2.9% | -8.9% | +2.7% | -5.1% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -5.3% | -5.8% | -20.5% | -0.3% | -17.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.